ESR1 and neoplasm: As expected, given that the decision of proposing adjuvant CT was left to the physician, patients receiving this therapy were more likely to have worse prognostic characteristics (larger tumors with a higher proliferation index, higher tumor grade and lower ER and PgR expression levels) than patients receiving HT only.